58-17H-51. Reclassification of benefits with respect to cancer treatment medications.
A health carrier may not reclassify benefits with respect to cancer treatment medications or increase a copayment, deductible, or coinsurance amount for covered cancer treatment medications that are injected or intravenously administered unless:
(1)The increase is applied generally to other medical or pharmaceutical benefits covered under the plan and is not done to circumvent §58-17H-50;
(2)The reclassification of benefits with respect to cancer treatment medications is done in a manner that is consistent with §§58-17H-50 to 58-17H-52, inclusive; or
(3)A health carrier is applying cost-sharing increases consistent with the annual increases in the cost of health care.
Source: SL 2015, ch 252, §2, eff. Jan. 1, 2016.